Vir Biotechnology News and Activities

Vir Biotechnology is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Vir Biotechnology is a company listed under the stock ticker VIR (US).

View the org chart displaying its 30 main executives

Most searched biographies at Vir Biotechnology

• Marianne De Backer, Chief Executive Officer and Director
• Janet Napolitano, Director
• Elliott Sigal, Director

Create your alert
to follow the executive moves at Vir Biotechnology.

Vir Biotechnology has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Vir Biotechnology

• Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026
• Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference
• Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results
• Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
• Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
• Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
• Vir Biotechnology to Participate in Upcoming Investor Conferences
• Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results
• Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
• Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
• View more press releases Close

Social media about Vir Biotechnology

• Vir Biotechnology on Wikipedia, Google News & Yahoo Finance
• Vir Biotechnology on LinkedIn, X (Twitter) & YouTube